Semaglutide Weight Management and Cardiovascular Risk Reduction slide image

Semaglutide Weight Management and Cardiovascular Risk Reduction

Agenda Introduction Insulin Daniel Bohsen & Martin Holst Lange GLP-1 in diabetes GLP-1 in obesity Insulin Icodec CagriSema in diabetes Oral semaglutide in diabetes Oral semaglutide in obesity Semaglutide 2.4 mg: STEP HFPEF Stephen Gough Martin Holst Lange Stephen Gough Stephen Gough Martin Holst Lange Q&A All O novo nordisk O
View entire presentation